Pharmacological or genetic inhibition of iNOS prevents cachexia‐mediated muscle wasting and its associated metabolism defects-Reference-Cited by-同舟云学术

Pharmacological or genetic inhibition of iNOS prevents cachexia‐mediated muscle wasting and its associated metabolism defects

Published:2021-06-07 Issue:7 Volume:13 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Sadek Jason¹²,Hall Derek T¹²³⁴,Colalillo Bianca¹²,Omer Amr¹²,Tremblay Anne‐Marie K¹²,Sanguin‐Gendreau Virginie¹²,Muller William¹²,Di Marco Sergio¹²,Bianchi Marco Emilio⁵^ORCID,Gallouzi Imed‐Eddine¹²⁶^ORCID

Affiliation:

1. Department of Biochemistry McGill University Montreal QC Canada

2. Rosalind & Morris Goodman Cancer Research Center McGill University Montreal QC Canada

3. Sprott Centre for Stem Cell Research Regenerative Medicine Program Ottawa Hospital Research Institute Ottawa ON Canada

4. Department of Cellular and Molecular Medicine Faculty of MedicineUniversity of Ottawa Ottawa ON Canada

5. Division of Genetics and Cell Biology Chromatin Dynamics Unit IRCCS San Raffaele Scientific Institute and Vita‐Salute San Raffaele University Milan Italy

6. KAUST Smart‐Health Initiative and Biological and Environmental Science and Engineering (BESE) Division King Abdullah University of Science and Technology (KAUST) Jeddah Saudi Arabia

Funder

Canadian Institutes of Health Research

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202013591

Reference131 articles.

1. Nuclear factor-kappa B activation in skeletal muscle of patients with chronic heart failure: correlation with the expression of inducible nitric oxide synthase

2. NF- B activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight

3. 3-Nitrotyrosine: A biomarker of nitrogen free radical species modified proteins in systemic autoimmunogenic conditions